REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative ColitisChristopher Ma, Talat Bessissow, Farhad Peerani et al.|The American Journal of Gastroenterology|2022Cited by 45
Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study)Neeraj Narula, John Marshall, Cara Pray et al.|Crohn s & Colitis 360|2024Cited by 11
DOP46 Tofacitinib for hospitalized acute severe Ulcerative Colitis – the TRIUMPH studyNeeraj Narula, John K. Marshall, Farhad Peerani et al.|Journal of Crohn s and Colitis|2024Cited by 8
Resolution of Rectal Bleeding by Day 7 in Acute Severe Ulcerative Colitis Is Prognostic for Postdischarge Corticosteroid-Free Clinical Remission and Endoscopic ImprovementNeeraj Narula, Parambir S. Dulai, Talat Bessissow et al.|The American Journal of Gastroenterology|2024Cited by 6